REGENXBIO Inc. (NASDAQ:RGNX) Q3 2024 Earnings Call Transcript
Operator: Welcome everyone to the Q3 2024 REGENXBIO Earnings Conference Call. [Operator Instructions] Please be advised that today’s conference is being recorded.
Regenxbio Inc. (RGNX)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Redmile Group Jeremy Green | 4,794,780 | $37,063,649 | -3% | 2.58% |
| 2. | Millennium Management Israel Englander | 1,322,344 | $10,221,719 | +407% | 0% |
| 3. | Balyasny Asset Management Dmitry Balyasny | 1,187,102 | $9,176,298 | +6% | 0.01% |
| 4. | Integral Health Asset Management Bhagwan Jay Rao | 900,000 | $6,957,000 | -30% | 0.59% |
| 5. | Citadel Investment Group Ken Griffin | 585,408 | $4,525,204 | +189% | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $22.00 | 49,000 | Large Shareholder, Other | 49,000 | 2015-09-22 | Filing | |
| $22.00 | 38,500 | Large Shareholder, Other | 38,500 | 2015-09-22 | Filing | |
| $22.00 | 87,500 | Large Shareholder, Other | 1,256,542 | 2015-09-22 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $10.11 | 10,000 | 11,286 | 2024-10-01 | Filing | ||
| $12.34 | 700 | 11,286 | 2024-09-03 | Filing | ||
| $11.50 | 9,300 | 11,986 | 2024-09-03 | Filing | ||
| $15.00 | 100 | 11,286 | 2024-08-01 | Filing | ||
| $14.59 | 400 | 11,386 | 2024-08-01 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 5,466,102 | $42,252,968 | 0% | |
| 2. | 4,136,517 | $31,975,276 | 0% | |
| 3. | 2,985,952 | $23,081,409 | 0% | |
| 4. | 2,185,851 | $16,896,628 | 0% | |
| 5. | 2,003,311 | $15,485,594 | 0% |
News See All
REGENXBIO Inc. (NASDAQ:RGNX) Q2 2024 Earnings Call Transcript
Operator: Welcome everyone to the Q2 2024 REGENXBIO's Earnings Conference Call. All lines have been placed on mute to prevent background noise.
Top 10 Small-Cap Stocks with Highest Upside Potential
Most giant companies start as small-cap, but by continuously developing and growing their earnings, their share price increases making them large or mega-cap companies, and along the way smart investors...
REGENXBIO Inc. (NASDAQ:RGNX) Q1 2024 Earnings Call Transcript
Operator: Good day and thank you for standing by. Welcome to REGENXBIO's First Quarter 2024 Earnings Conference Call. At this time, all participants are in a listen-only mode.
REGENXBIO Inc. (NASDAQ:RGNX) Q4 2023 Earnings Call Transcript
REGENXBIO Inc. misses on earnings expectations. Reported EPS is $-1.43 EPS, expectations were $-1.27. REGENXBIO Inc.
REGENXBIO Inc. (NASDAQ:RGNX) Q3 2023 Earnings Call Transcript
Operator: Good day, and thank you for standing by. Welcome to REGENXBIO's Third Quarter 2023 Earnings Conference Call. At this time, all participants are in a listen-only mode.
REGENXBIO Inc. (NASDAQ:RGNX) Q2 2023 Earnings Call Transcript
Operator: Good day, and thank you for standing by. Welcome to the Q2 2023 REGENXBIO Earnings Conference Call. At this time, all participants are in a listen-only mode.
REGENXBIO Inc. (NASDAQ:RGNX) Q1 2023 Earnings Call Transcript
Operator: Good day, and thank you for standing by. Welcome to the REGENXBIO Inc. First Quarter 2023 Conference Call. Please be advised that today's conference is being recorded.
REGENXBIO Inc. (NASDAQ:RGNX) Q4 2022 Earnings Call Transcript
Operator: Hello, and thank you for standing by. Welcome to the Q4 and Full Year 2022 REGENXBIO Earnings Call. At this time, all participants are in a listen-only mode.
11 Cheap Healthcare Stocks To Invest In
Healthcare is one of the biggest sectors in the world. According to a research report, the healthcare consumer market size was $332.391 billion and is expected to reach $667.37 billion by 2028.
Billionaire Hedge Funds
